Literature DB >> 36196064

Postoperative nosocomial COVID-19 infection in surgical patients during pandemic: A prospective observational cohort study.

Narjes Mohammadzadeh1, Alireza Abkhoo1, Mohammad Ashouri1, Amirmohsen Jalaeefar2, Amirmasoud Kazemzadeh Houjaghan3, Behnam Ghorbani1, Sara Ataie-Ashtiani4, Mohammadreza Salehi5, Ali Jafarian6.   

Abstract

Background: increased pressure on healthcare systems and possible risk of nosocomial COVID-19 infection during pandemic urged many guidelines to severely restrict the number of operations. The aim of this study was to investigate the risk of COVID-19 infection and its complications in patients undergoing urgent or elective operations.
Methods: a prospective observational cohort study was conducted in a tertiary surgical center and all patients with no preoperative history of COVID-19 undergoing elective or emergent surgeries were included in this investigation. chest computed tomography (CT) scan or polymerase chain reaction (PCR) test were performed on patients before and after surgery.
Results: 183 patients who underwent an operation were enrolled in this study. In postoperative follow-up, 12 patients were positive for COVID-19 infection as identified by RT-PCR and non-contrasted chest CT scans. Regrettably, 2 individuals passed with one of these individuals dying as a direct result of COVID-19 infection. All the 12 cases of post-operative COVID-19 patients underwent elective surgeries.
Conclusion: the gathered results indicate a need for the re-evaluation of the risks of operation during the COVID-19 pandemic. If operations are performed while observing protective and preventative protocols, the risk of post-operative nosocomial COVID-19 is significantly reduced. Hence, the consequences imposed on patients by the delay or cancellation of operations (most notably in cancer cases) may outweigh the risk of post-operative COVID-19 infections.
© 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.

Entities:  

Keywords:  COVID-19; Pandemic; SARS-Cov-2; Surgery; Urgent surgery; elective surgery

Year:  2022        PMID: 36196064      PMCID: PMC9523904          DOI: 10.1016/j.amsu.2022.104730

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


Introduction

During the December of 2019, an emerging disease conclusively changed health-care systems worldwide. The COVID-19 virus was first identified in the Wuhan region of China and progressed to spread to other nations over the successive months [1]. Accordingly, March of 2020, the World Health Organization announced its recognition of a global pandemic [1,2]. COVID-19 infection presentation ranges from asymptomatic infection to cases of lethal pneumonia [3]. As of March 2021, this virus has regrettably resulted in over 120 million recorded cases of infection and 2.7 million deaths globally [2]. The first case of COVID-19 in Iran was reported on February 19th, 2020 in Qom, and after this, the virus rapidly spread all over the country [4] (see Table 1 ).
Table 1

Tabulation of post-operative COVID-19 status of surgical patients and their demographic information as well as comorbidities.

VariableTotal patients n = 183 (100%)COVID-19 (−) patients n = 171 (93.4%)COVID-19 (+) patients N = 12 (6.6%)P-Value
Diabetes Mellitus27 (14.8%)26 (15.2%)1 (8.3%)1.000
Hypertension40 (21.9%)39 (22.8%)1 (8.3%)0.468
Ischemic Heart Disease32 (17.5%)30 (17.5%)2 (16.7%)1.000
Renal Disorder4 (2.2%)4 (2.3%)0 (0%)1.000
Steroid Use7 (3.8%)6 (3.5%)1 (8.3%)0.383
Cancer56 (30.6%)53 (31%)3 (25%)0.758
Recent Chemotherapy18 (9.8%)15 (8.8%)3 (25%)0.100
Respiratory Disorder6 (3.3%)5 (2.9%)1 (8.3%)0.338
No Comorbidity106 (57.9%)99 (57.9%)7 (58.3%)1.000
Surgical priority
Elective132 (72.1%)120 (70.1%)12 (100%)0.022
Emergent51 (27.9%)51 (29.8%)0 (0%)
Age (Mean ± SD, Years)47.7 ± 16.5449.86 ± 16.0549.17 ± 13.690.135
Gender
Male85 (46.4%)78 (45.6%)5 (41.6%)0.289
Female98 (53.6%)93 (54.3%)7 (58.3%)
Body Mass Index (Mean ± SD)25.70 ± 4.2925.70 ± 4.4926.39 ± 5.810.241
Body Mass Index (Categorical)
Underweight8 (4.4%)8 (4.7%)0 (0%)0.876
Normal75 (41%)70 (40.9%)5 (41.7%)
Overweight76 (41.5%)71 (41.5%)5 (41.7%)
Obese24 (13.1%)22 (12.9%)2 (16.7%)
Pre-operative hospitalization days (Mean ± SD)1.73 ± 2.241.74 ± 2.281.55 ± 1.290.434
Operation time (Mean ± SD)155.6 ± 110.3152.5 ± 109.5200.7 ± 116.20.932
Tabulation of post-operative COVID-19 status of surgical patients and their demographic information as well as comorbidities. Admission of an unprecedentedly high number of patients to unprepared hospitals due to the COVID-19 pandemic resulted in increased pressure on healthcare systems [5,6]. The shortage of hospital and Intensive Care Unit (ICU) beds and established guidelines with the aim of reducing the risk of COVID-19 infections in hospitalized patients significantly reduced the number of operations taking place during the pandemic [7,8]. Furthermore, it was suggested that patients who undergo operations are at a higher risk of nosocomial COVID-19 infection due to increased viral exposure in hospital settings in addition to their immunosuppressed state [9]. Synchronously, literature indicated high mortality and morbidity rate in COVID-19 cases after surgeries [10,11]. The discussed guidelines provided instructions for all aspects of the health care system including health care personnel, patients, transportation processes, operating rooms, and equipment use [12]. Thus, guidelines severely restricted the number of elective operations, and urgent operations were completed non-laparoscopically and with regional anesthesia [[13], [14], [15], [16]]. This was not only due to the high risk of COVID-19 infection but also to the fact that the majority of medical supplies were devoted to COVID-19 management [17]. Similarly, within our referral center, hospital protocols were established and followed, resulting in the cancelation of the majority of elective surgeries [18]. As rapid diagnostic tests for COVID-19 have become widely available and the COVID-19 pandemic has continued, several surgical centers are applying screening systems for COVID-19 testing of patients before admission [19]. If a positive result is obtained, surgeries are postponed or are only performed with special precautions [20]. Despite the discussed guidelines and protocols, the exact risk of COVID-19 infection in admitted surgical cases and the resulting complications has not yet been determined. Consequently, this study aims to investigate the risk of COVID-19 infection and its complications in patients undergoing urgent or elective operations in our tertiary center and assess the safety of performing operations in terms of COVID-19 infection during the pandemic.

Methods

The main goal of this study is to evaluate the rate of postoperative COVID-19 infection and its resultant complications and mortality to provide a basis for surgical risk assessment, ensuring the delivery of the best medical care to patients a prospective observational study was conducted in a tertiary surgical center. Patients who underwent surgery from April to September 2020 was enrolled in this study.This period coincided with the peak of the COVID-19 pandemic in Iran when many non-urgent operations were canceled. This research is fully compliant with the STROCSS 2021 criteria [21] and registered in the Research Ethics Committees of Vice-Chancellor in Research Affairs of Tehran University of Medical Sciences. The approval ID is IR.TUMS.VCR.REC.1399.216. https://ethics.research.ac.ir/ProposalCertificateEn.php?id=128698&Print=true&NoPrintHeader=true&NoPrintFooter=true&NoPrintPageBorder=true&LetterPrint=true. All patients over 18 years of age, while they had no evidence of COVID-19 infection undergoing elective or emergent surgeries in a tertiary hospital were included in this investigation. Patients suspected of COVID-19 infection based on preoperative chest computed tomography (CT) scan or positive polymerase chain reaction (PCR) test were excluded from the study. Moreover, patients with a positive COVID-19 test within 3 days after surgery were excluded due to the likelihood of the acquirement of this infection pre-operation. For enrolled patients, suspicious postoperative symptoms followed by a definitive diagnosis based on PCR testing and Chest CT scans 3–14 days post-surgery was considered as positive post-operative COVID-19 infections. Demographic information and comorbidities were recorded and tabulated. Based on surgical protocols, all patients underwent a non-contrasted chest CT scan but a reverse transcription polymerase chain reaction (RT-PCR) of the oropharynx and nasopharynx was only done for symptomatic patients. Information regarding the operation, including operation type, anesthesia, and operation duration were recorded. All included patients were followed up after surgery and were assessed every day during their hospitalization in addition to follow up appointments 2 and 6 weeks after discharge in person or by phone. During these appointments, they were asked about and examined for suspicious symptoms indicative of COVID-19 infection. While following up, if there was any suspicion for COVID-19 infection, a non-contrasted chest CT scan and RT-PCR test from a nasopharyngeal and oropharyngeal swab was completed. For patients with postoperative COVID-19 infection, the percentage of lung involvement, re-hospitalization, ICU admission due to COVID-19, and its complications and mortality were recorded. For statistical analysis, the application SPSS version 23 was used. Continuous data was reported as mean ± standard deviation while discrete data was reported as percentages and frequencies. Independent t-test was used to compare continuous data, whereas chi-square test and Fisher's exact test was used to compare discrete data.

Results

After excluding patients with pre-operative COVID-19 infections and those with the mentioned exclusion criteria, a total of 183 COVID-19 negative patients who underwent an operation were enrolled in this study. 98 participants (53.6%) were female, and 85 participants (46.4%) were male. Furthermore, the mean age within the sample was 47.06 ± 16.54 years and the mean body mass index (BMI) of the participants was 25.79 ± 4.29. 76 patients (41%) were overweight, 24 (13.3%) were obese, 75 (41%) were within the normal BMI range, and 8 (4.47%) were underweight. The mean pre-operative hospital admission was 1.74 ± 2.28 days. The indication and type of surgeries included as; Head & neck cancer 20 (11%), Upper GI cancer 10 (5.5%), Hepatobiliary cancer 20 (11%), Breast cancer 25 (13.5%), Colorectal cancer 8 (4%), Gynecologic cancer 4 (2%), Cholecystectomy 38 (21%), Appendectomy 16 (11.5%), Liver transplant 1 (0.5%), Laparotomy due to peritonitis or obstruction 16 (8%), Tissue repair after traumatic lacerations 11 (5.3%) and Coronary artery bypass graft 14 (6.7%). Among the participants, 27 (17.5%) had diabetes mellitus, 40 (21.9%) had hypothyroidism, 32 (17.5%) had ischemic heart disease, 4 (2.2%) had renal disease, 56 (30.6%) had cancer, and 6 (3.3%) had respiratory disease. 80 patients (9.8%) underwent chemotherapy within three weeks pre-operation. 106 patients (57.9%) did not have any underlying conditions or comorbidities. Moreover, 132 patients underwent an elective operation, and 51 patients underwent a non-elective operation. During the pre-operation admission, it was noted that 1 patient had chronic myeloid leukemia (CML) and underwent an elective open splenectomy associated with a resultant prolonged hospital stay (44 days). Thus, this patient was excluded from the study. In the postoperative follow-up, 12 patients were positive for COVID-19 infection as identified by RT-PCR and non-contrasted chest CT scans. Regrettably, 2 individuals passed with one of these individuals dying as a direct result of COVID-19 infection. All the 12 cases of post-operative COVID-19 patients underwent elective surgeries and the mean age of patients in this group was 49.17 ± 13.69 years while those with no post-operative COVID-19 had a mean age of 46.99 ± 16.74 years, demonstrating no significant difference in age between the two groups. The mean operation time in the COVID-19 positive group was 200.75 ± 116.25 minutes, while this value was 152.5 ± 109.5 minutes in the COVID-19 negative group. Moreover, no significant difference was observed between the two groups in terms of BMI and sex distribution. The mean hospital stay duration before the operation was 1.55 ± 1.29 days in the COVID-19 positive group, while this value was 1.74 ± 2.28 days in the healthy group, once again demonstrating no significant difference between the two groups. However, operation time was significantly higher in elective surgeries. (176.7 ± 115.3 minutes and 101.1 ± 72.4 minutes, P-value = 0.001). Interestingly, the distribution of underlying diseases, such as diabetes, hyperthyroidism, ischemic heart disease, renal disorders, cancer, respiratory disorders, and recent chemotherapy and steroid consumption, did not show a significant difference between the post-operative COVID-19 positive and negative groups.

Discussion

The COVID-19 pandemic significantly affected the efficacy of health care systems as well as the degree and type of care provided to patients all over the world [22]. Moreover, the fear of post-operative complications due to COVID-19 significantly limited and continues to limit both elective and urgent operations [9]. Many patients postponed their medical visits and admission due to concerns about COVID-19 infection [23]. These delays, whether because of patient or physician concerns or because of the devotion of supplies to COVID-19 management, could result in increased mortality and morbidity globally and significantly reduce patient quality of life due to delayed medical treatment [24,25]. Thus far, some studies report a high risk of COVID-19 infection and its related morbidity and mortality in hospital settings which suggests the need for careful observation of patients and the use of appropriate guidelines [26]. Thus far, literature suggests various directions for COVID-19 management in the surgical system including canceling all elective operations or observing tight protocols by operation room personnel [27]. Mihalj et al. suggest that PCR tests be used for the screening of all referral patients from other centers and all symptomatic patients before elective surgery in addition to PCR tests and chest CT scans for urgent cases [28]. Furthermore, De Simone et al. have provided a comprehensive approach for the management of COVID-19 infection in surgical patients and have suggested PCR tests and chest CT scans for all urgent cases and isolation of patient until screening test results are ready [29]. In our medical center, operations were performed by complete observance of pre-operative, intraoperative, and postoperative protocols. All patients were screened for COVID-19 before operations, and symptomatic patients were tested using RT-PCR. Visiting the patients was only allowed by medical staff to prevent viral spread. All patients were obligated to wear face masks except those requiring oxygen supplements or patients with dyspnea and all healthcare providers always wore face masks and observed infection protection protocols. In our center, no routine screening for COVID-19 was done for healthcare providers, and only symptomatic healthcare staff were evaluated for COVID-19. To add, patients with COVID-19 were admitted to separate wards and operated on in specifically allocated operating rooms. Finally, based on hospital protocol, it was ensured that both pre-operative and postoperative hospital stay were reduced as much as possible. In a study by Axiotakis et al. study 9 cases out of 511 patients undergoing operation were infected with COVID-19. Prior to implementing pre-operative testing in their surgical center. Furthermore, they noted that the rate of COVID-19 infection has been reported to be related to Diabetes and ischemic heart disease [30]. In our study, 12 patients became symptomatic and infected with COVID-19, 2 of whom passed, 1 as a direct result of COVID-19. Thus, the observed mortality rate was less than that observed in similar studies (8.3%). In the Aminian et al. study during the onset of the pandemic, it was reported that three patients developed COVID-19 after the operation with 2 of these individuals passing [31]. In this study, no relationship was observed between underlying diseases and COVID-19 infection in the post-operative period; though, due to the risk of severity and mortality of COVID-19 in patients with comorbidity in the previous studies [11,32,33], it is essential to consider underlying diseases when planning an operation. Moreover, despite the results cited in previous studies, our study did not show a significant difference between genders in post-operative COVID-19 infection [33]. In our study, the incidence of post-operative COVID-19 infection only occurred in patients undergoing elective surgeries. This may be due to the simpler procedures, shorter hospitalization time, and the limited number of patients in non-elective surgeries and can be explained based on the significant difference observed between elective and non-elective operation duration. Although the present study did not show any relationship between the pre-operative length of stay and COVID-19 infection, reduced viral exposure due to observing preventive protocols and reducing the length of hospital stay where possible is key in reducing the risk of COVID-19 and further studies are required to clarify and amend guidelines [34]. One-third of the patients in the present study had cancer. Postponing elective but necessary surgeries for malignant diseases during the COVID-19 pandemic has resulted in increased mortality and morbidity due to metastatic and inoperable cases [34]. Considering the reduced risk of COVID-19 infection with the performed preventive measure and the risk of delaying operation in cancer patients, undergoing an operation while observing protocols is likely more beneficial for this group of patients [35,36]. The limitations of this study include the small sample size and the resulting low number of COVID-19 cases, hence, reducing the study's power and generalizability. Furthermore, it must be noted that non-inclusion of asymptomatic COVID-19 patients who presented with negative RT-PCR and no abnormal findings in the chest CT scans is also a limitation. Furthermore, future investigations comparing the postoperative complications between patients with COVID-19 and healthy individuals should also be conducted and will help shed light on the risks and benefits involved in conducting operations during the pandemic for policy makers. Despite the mentioned limitations, the gathered results indicate a need for the re-evaluation of the risks of operation during the COVID-19 pandemic. If operations are performed while observing protective and preventative protocols, the risk of post-operative nosocomial COVID-19 are significantly reduced. Hence, the risks and the reduction in the quality of care provided and patient quality of life by the delay or cancellation of operations (most notably in cancer cases) may outweigh the risk of post-operative COVID-19 infections although a case-by-case analysis of the risks and comorbidities of each patient is likely required.

Ethical approval

Ethical approval was requested and obtained from the “Tehran university of medical sciences” ethical committee.

Source of funfing

Tehran university of medical sciences.

Author contribution

All authors contribute in this study equally.

Consent

This study did not interfere with patients care but all patients was infirmed and consent was obtained.

Registration of research studies

Name of the registry: Unique Identifying number or registration ID: Hyperlink to your specific registration (must be publicly accessible and will be checked):

Garantor

Mohammad Ashouri.

Provenance and peer review

Not commissioned, externally peer reviewed.

Declaration of competing interest

The authors have no conflict of interest.
  33 in total

1.  Guidance for management of cancer surgery during the COVID-19 pandemic.

Authors:  Christian Finley; Anubha Prashad; Natasha Camuso; Corinne Daly; Armen Aprikian; Chad G Ball; James Bentley; Dhany Charest; Paola Fata; Lucy Helyer; Daniel O'Connell; Husein Moloo; Andrew Seely; Joel Werier; Toni Zhong; Craig C Earle
Journal:  Can J Surg       Date:  2020-05-01       Impact factor: 2.089

2.  Implementation of Preoperative Screening Protocols in Otolaryngology During the COVID-19 Pandemic.

Authors:  Matthew J Urban; Tirth R Patel; Richard Raad; Phillip LoSavio; Kerstin Stenson; Samer Al-Khudari; Thomas Nielsen; Inna Husain; Ryan Smith; Peter C Revenaugh; R Mark Wiet; Peter Papagiannopoulos; Pete S Batra; Bobby A Tajudeen
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-26       Impact factor: 3.497

3.  Management of colon and rectal cancers during COVID-19 pandemic: A clinical guideline (TUMS-CRC-CoV19 Guideline).

Authors:  Mohammad Reza Keramati; Behnam Behboudi; Seyed Mohsen Ahmadi-Tafti; Alireza Kazemeini; Amir Keshvari; Faeze Salahshour; Mahdi Aghili; Foroogh Alborzi; Najmeh Aletaha; Mohammad Babaei; Mohammad Naeem Bangash; Nasser Ebrahimi-Daryani; Amir Hossein Emami; Farshid Farhan; Peiman Haddad; Mohammad Kalani; Amirhosein Naseri; Farhad Shahi; Mohammad Sadegh Fazeli
Journal:  Med J Islam Repub Iran       Date:  2020-09-29

4.  The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study.

Authors:  Katie Spencer; Christopher M Jones; Rebecca Girdler; Catherine Roe; Michael Sharpe; Sarah Lawton; Louise Miller; Philippa Lewis; Mererid Evans; David Sebag-Montefiore; Tom Roques; Rebecca Smittenaar; Eva Morris
Journal:  Lancet Oncol       Date:  2021-01-22       Impact factor: 41.316

Review 5.  Nosocomial infection of COVID‑19: A new challenge for healthcare professionals (Review).

Authors:  Qiu Du; Dingding Zhang; Weimin Hu; Xuefei Li; Qiongrong Xia; Taishen Wen; Haiping Jia
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

6.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.

Authors:  Chor-Cheung Frankie Tam; Kent-Shek Cheung; Simon Lam; Anthony Wong; Arthur Yung; Michael Sze; Yui-Ming Lam; Carmen Chan; Tat-Chi Tsang; Matthew Tsui; Hung-Fat Tse; Chung-Wah Siu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-17

7.  Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.

Authors:  Rachel Riera; Ângela Maria Bagattini; Rafael Leite Pacheco; Daniela Vianna Pachito; Felipe Roitberg; Andre Ilbawi
Journal:  JCO Glob Oncol       Date:  2021-02

8.  Surgical Outcomes During COVID-19 Pandemic.

Authors:  Andrea Nachon-Acosta; Gustavo Martinez-Mier; Victor Flores-Gamboa; Octavio Avila-Mercado; Indira Morales Garcia; Carlos Yoldi-Aguirre; Irais Olivares-Garcia; Maritza De la Paz-Roman
Journal:  Arch Med Res       Date:  2021-01-22       Impact factor: 2.235

9.  COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period.

Authors:  Ali Aminian; Saeed Safari; Abdolali Razeghian-Jahromi; Mohammad Ghorbani; Conor P Delaney
Journal:  Ann Surg       Date:  2020-07       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.